Literature DB >> 15283101

Current issues in the management of necrotizing enterocolitis.

Marion C W Henry1, R Lawrence Moss.   

Abstract

Necrotizing enterocolitis (NEC) is the most common surgical emergency in the neonatal intensive care unit and remains a major cause of death in neonates. Although the pathophysiology of NEC has not been completely elucidated, progress has been made in the characterization of the molecular events which may take place during an episode of ischemia. This possible initiating event is followed by a complex cascade of inflammatory mediators active in NEC: epidermal growth factor, platelet-activating factor, and, nitric oxide. Additionally, unique characteristics of the premature gut are thought to be crucial to the development of NEC. The diagnosis of NEC continues to be based on clinical and radiographic features. Several new laboratory tests are under investigation for the purposes of earlier diagnosis, but none have prevailed at this time. Both exploratory laparotomy, with intestinal resection and peritoneal drainage are widely practiced. Mortality rates remain high and have improved little over the last couple of decades. Therefore, prevention remains crucial in order to decrease the incidence of NEC. Cautious feeding regimens, the use of maternal breast milk, passive immunization, and the use of probiotics have all been suggested but not proven as possible preventive methods. Although many advances have been made, significant opportunity remains to improve our understanding of the disease process and to develop better strategies for prevention and treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15283101     DOI: 10.1053/j.semperi.2004.03.010

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  15 in total

1.  Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.

Authors:  Andrei Radulescu; Hong-Yi Zhang; Xiaoyi Yu; Jacob K Olson; Amanda K Darbyshire; Yan Chen; Gail E Besner
Journal:  J Pediatr Surg       Date:  2010-10       Impact factor: 2.545

2.  Could clinical scores guide the surgical treatment of necrotizing enterocolitis?

Authors:  Vicente Ibáñez; Miguel Couselo; Verónica Marijuán; Juan José Vila; Carlos García-Sala
Journal:  Pediatr Surg Int       Date:  2011-10-15       Impact factor: 1.827

Review 3.  Necrotizing enterocolitis in newborns: pathogenesis, prevention and management.

Authors:  Alecia M Thompson; Matthew J Bizzarro
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Signal transduction pathways involved in oxidative stress-induced intestinal epithelial cell apoptosis.

Authors:  Yuning Zhou; Qingding Wang; B Mark Evers; Dai H Chung
Journal:  Pediatr Res       Date:  2005-12       Impact factor: 3.756

5.  Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis.

Authors:  Vanaja N Alexander; Veronika Northrup; Matthew J Bizzarro
Journal:  J Pediatr       Date:  2011-04-13       Impact factor: 4.406

6.  Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis.

Authors:  Andrei Radulescu; Xiaoyi Yu; Nathan D Orvets; Yan Chen; Hong-Yi Zhang; Gail E Besner
Journal:  J Pediatr Surg       Date:  2010-04       Impact factor: 2.545

7.  Evaluating the efficacy of different types of stem cells in preserving gut barrier function in necrotizing enterocolitis.

Authors:  Christopher J McCulloh; Jacob K Olson; Yijie Wang; Jennifer Vu; Sarah Gartner; Gail E Besner
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

Review 8.  Multi-modal approach to prophylaxis of necrotizing enterocolitis: clinical report and review of literature.

Authors:  G Schmolzer; B Urlesberger; Michaela Haim; J Kutschera; G Pichler; E Ritschl; B Resch; F Reiterer; W Müller
Journal:  Pediatr Surg Int       Date:  2006-06-15       Impact factor: 1.827

9.  Stem cells and necrotizing enterocolitis: A direct comparison of the efficacy of multiple types of stem cells.

Authors:  Christopher J McCulloh; Jacob K Olson; Yu Zhou; Yijie Wang; Gail E Besner
Journal:  J Pediatr Surg       Date:  2017-03-18       Impact factor: 2.545

10.  Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life.

Authors:  Qing Yang; P Brian Smith; Ronald N Goldberg; C Michael Cotten
Journal:  Neonatology       Date:  2008-09-11       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.